Skip to main content

Table 5 Onset time for drug-related adverse events: diarrhea, hand-foot skin reaction, and liver dysfunction

From: Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study

Time of onset

Total

Child-Pugh A

Child-Pugh B

Not evaluable

Diarrhea

35/39

25/28

7/8

3/3

 0–30 days

12/13

8/8

4/5

0/0

 31–60 days

4/4

3/3

1/1

0/0

 61–90 days

5/5

4/4

0/0

1/1

  > 90 days

14/17

10/13

2/2

2/2

Hand-foot skin reaction

63/64

51/51

7/8

5/5

 0–30 days

37/38

29/29

5/6

3/3

 31–60 days

11/12

9/10

1/1

1/1

 61–90 days

5/5

5/5

0/0

0/0

  > 90 days

10/9

8/7

1/1

1/1

Liver dysfunction

0/46

0/30

0/9

0/7

 0–30 days

0/6

0/2

0/2

0/2

 31–60 days

0/2

0/1

0/1

0/0

 61–90 days

0/10

0/8

0/1

0/1

  > 90 days

0/28

0/19

0/5

0/4

  1. Data are presented as represented as number of drug-related adverse events / number of adverse events